Susquehanna International Group, LLP Bio Xcel Therapeutics, Inc. Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$0.53 - $1.34 $63,441 - $160,398	-119,700 Reduced 90.54%	12,500 $7,000
Q2 2024 Aug 15, 2024	BUY	$1.14 - $2.97 $7,409 - $19,305	6,500 Added 5.17%	132,200 $169,000
Q1 2024 May 07, 2024	SELL	$1.95 - $4.04 $126,750 - $262,600	-65,000 Reduced 34.08%	125,700 $354,000
Q4 2023 Feb 14, 2024	BUY	$2.32 - $5.51 $185,600 - $440,800	80,000 Added 72.27%	190,700 $562,000
Q3 2023 Nov 14, 2023	SELL	$2.49 - $11.85 $427,533 - $2.03 Million	-171,700 Reduced 60.8%	110,700 $280,000
Q2 2023 Aug 11, 2023	BUY	$6.39 - $28.58 $1.6 Million - $7.16 Million	250,400 Added 782.5%	282,400 $1.88 Million
Q1 2023 May 16, 2023	SELL	$17.7 - $33.24 $56,640 - $106,368	-3,200 Reduced 9.09%	32,000 $597,000
Q4 2022 Feb 14, 2023	SELL	$10.25 - $22.43 $145,550 - $318,506	-14,200 Reduced 28.74%	35,200 $756,000
Q3 2022 Nov 14, 2022	SELL	$11.19 - $17.89 $325,629 - $520,599	-29,100 Reduced 37.07%	49,400 $584,000

6.99M

101K

198K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $17.4M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.